Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myrrhinil-Intest versus mesalazine for maintenance of remission in ulcerative colitis
2007-007928-18Phase 4Completed
- Sponsor
- Repha
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in autoimmune colitis comparing Myrrhinil-Intest arm with Mesalazine arm (2 arms). Primary endpoint: Averaged colitis activity index over treatment period. Started Nov 2008; status: completed.
02
Drugs
Myrrhinil-IntestSalcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2007-007928-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007928-18.